Kiga, K., Tan, X., Ibarra-Chávez, R., Watanabe, S., Aiba, Y., Sato’o, Y., . . . Cui, L. (2020). Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria. Nature Portfolio.
Chicago Style (17th ed.) CitationKiga, Kotaro, et al. Development of CRISPR-Cas13a-based Antimicrobials Capable of Sequence-specific Killing of Target Bacteria. Nature Portfolio, 2020.
MLA (8th ed.) CitationKiga, Kotaro, et al. Development of CRISPR-Cas13a-based Antimicrobials Capable of Sequence-specific Killing of Target Bacteria. Nature Portfolio, 2020.
Warning: These citations may not always be 100% accurate.